About
ADARx Pharmaceuticals Inc. is a genetic medicine company focusing on oligonucleotide-based therapeutics including base editing of mRNA transcripts. In that regard, we discover and develop innovative therapeutics that can utilize a family of endogenous enzymes called adenosine deaminase acting on RNA (ADAR) to precisely target and correct single point mutations on a mRNA, thus the production of desired and functional protein is restored. Our mission is to provide effective and safe therapeutics to patients who suffer from currently undruggable diseases.
We are well-financed by a group of renowned VC firms, and our brand-new facility is located in San Diego, California.